Express License
Our Express License is a fast, simple, and accessible way for startups and small companies to get non-exclusive access to the CVC’s CRISPR/Cas9 patent portfolio for internal research use. We recognize the unique challenges these organizations face and aim to remove barriers to accessing this transformative technology.Â
Your company must have fewer than 15 employees, have less than $10M in funding, be actively or seek to be using CRISPR technology for internal research purposes only & not currently or aim to commercialise CRISPR technology under this license. If your company falls outside of the listed criteria, contact us to discuss a bespoke license that suits your needs!
ERS’s collaborative licensing approach promotes widespread adoption of CRISPR/Cas9 technology.
Non-exclusive licenses are available to companies involved in development and commercialization of CRISPR/Cas9 technology, products, and services.
By loading the video, you agree to YouTube's privacy policy.
Learn more
Licenses are available in a wide range of fields
- Pharmaceutical & Biotechnology
- CROs, CMOs & Tool Providers
- Companion Animal & Veterinary Applications
- Agriculture & Livestock applications
- Industrial & Synthetic Biology Applications
Some of our 100+ Licensees
Research
Production
CMO’s
Reagents
